NeuroOne Medical Technologies C

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 64130M209 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Merchant Adventure Fund, L.P. 13G/A	13.6%	4,200,000	13G/A	2/4/2025 Event 12/31/2024
Bleichroeder LP 13G	8.0%	4,000,000	13G	8/14/2025 Event 6/30/2025
Bleichroeder LP	8.0%	4,000,000
Bleichroeder Holdings LLC	8.0%	4,000,000
Andew Gundlach	8.0%	4,000,000
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Manchester Management Co LLC 13G/A	4.9%	1,583,332	13G/A	2/14/2025 Event 12/31/2024
Manchester Explorer, L.P.	4.1%	1,333,333
Manchester Management Company, LLC	4.6%	1,499,999
Manchester Management PR, LLC	4.6%	1,499,999
James E. Besser	4.9%	1,583,332
Morgan C. Frank	4.4%	1,416,666
AWM Investment Company, Inc. 13G/A	4.8%	2,354,167	13G/A	5/9/2025 Event 3/31/2025
Sio Capital Management, LLC 13G/A	4.7%	2,360,635	13G/A	11/12/2025 Event 9/30/2025
Lytton Laurence W 13G/A	2.6%	1,295,288	13G/A	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC 13G/A	2.6%	798,762	13G/A	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC	2.6%	798,762
Wilmot B. Harkey	2.6%	798,762
Daniel Mack	2.6%	798,762

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	2	2.81 k	$8.55 k	$0
2026 Q1	32	11.8 M	$9.14 M	$78.8 k
2025 Q4	39	12.5 M	$9.44 M	$87.5 k
2025 Q3	36	14.4 M	$12.8 M	$57.9 k
2025 Q2	32	13.5 M	$9.18 M	$84.9 k
2025 Q1	21	1.93 M	$1.64 M	$60.9 k
2024 Q4	22	1.62 M	$1.34 M	$33.7 k
2024 Q3	23	2.42 M	$2.40 M	$0
2024 Q2	21	3.69 M	$2.95 M	$0
2024 Q1	20	2.85 M	$3.42 M	$0
2023 Q4	25	4.08 M	$6.44 M	$24.0 k
2023 Q3	22	2.62 M	$2.33 M	$11.0 k
2023 Q2	15	939 k	$1.13 M	$0
2023 Q1	16	963 k	$1.55 M	$0
2022 Q4	24	759 k	$910 k	$8.88 k
2022 Q3	12	410 k	$686 k	$0
2022 Q2	11	480 k	$394 k	$0
2022 Q1	12	707 k	$777 k	$0
2021 Q4	17	1.95 M	$3.78 M	$0
2021 Q3	10	251 k	$989 k	$0
2021 Q2	4	411 k	$2.73 M	$0